Smarter Decisions,
Better Care

UpToDate synthesizes the most recent medical information into evidence-based practical recommendations clinicians trust to make the right point-of-care decisions.

  • Rigorous editorial process: Evidence-based treatment recommendations
  • World-Renowned physician authors: over 5,100 physician authors and editors around the globe
  • Innovative technology: integrates into the workflow; access from EMRs

Choose from the list below to learn more about subscriptions for a:


Subscribers log in here


Ablative laser resurfacing for skin rejuvenation

INTRODUCTION

Ablative laser resurfacing is used to target the cutaneous signs of photodamage that progressively increase with age and occur most prominently in individuals with fair skin. Through the ablation of the epidermis and portions of the superficial dermis as well as the induction of collagen remodeling in the deeper dermis, ablative laser resurfacing can reduce rhytides (wrinkles), dyschromia, vascular changes, and skin laxity.

The mechanism of action, efficacy, adverse effects, and administration of traditional and fractional ablative laser resurfacing for skin rejuvenation will be discussed here. The basic principles of laser therapy for cutaneous lesions are reviewed separately. (See "Principles of laser and intense pulsed light for cutaneous lesions".)

OVERVIEW

Technology for ablative laser resurfacing has continuously evolved. The procedure was first performed in the 1980s with the continuous wave carbon dioxide (CO2) laser. Use of this laser was complicated by an unfavorably high risk of adverse effects, and the subsequent development of pulsed CO2 lasers and rapidly scanning continuous wave CO2 lasers improved the safety of treatment [1]. In the 1990s the erbium:yttrium aluminum garnet (Er:YAG) laser was introduced as an alternative device for ablative laser resurfacing. Advantages of Er:YAG lasers included more precise control over the depth of cutaneous ablation and a lower incidence of adverse effects.

For a number of years, the CO2 and Er:YAG lasers were the primary lasers used for ablative laser resurfacing for skin rejuvenation, with CO2 lasers considered the gold standard for this indication. However, in the early 2000s, the approach to laser skin rejuvenation was dramatically altered by the development of fractional lasers, which emit numerous narrow, microscopic columns of laser light. Fractional lasers treat only a defined fraction of the skin within a targeted area, leaving intervening areas of skin unaffected (figure 1). The reservoir of undamaged skin adjacent to sites of laser injury allows for rapid reepithelialization after treatment through the migration of viable cells into wounded areas.

Aside from the repair of photodamaged skin, ablative laser resurfacing is used for a variety of other indications, such as the treatment of scars, actinic keratoses, epidermal nevi, and other cutaneous lesions and disorders. Nonablative traditional and fractional lasers also have been studied for facial rejuvenation; however, these lasers generally are less efficacious than their ablative counterparts for this indication [2].

                           

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Jun 2014. | This topic last updated: May 6, 2014.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2014 UpToDate, Inc.
References
Top
  1. Ross EV, Grossman MC, Duke D, Grevelink JM. Long-term results after CO2 laser skin resurfacing: a comparison of scanned and pulsed systems. J Am Acad Dermatol 1997; 37:709.
  2. Alexiades-Armenakas MR, Dover JS, Arndt KA. The spectrum of laser skin resurfacing: nonablative, fractional, and ablative laser resurfacing. J Am Acad Dermatol 2008; 58:719.
  3. Alster TS, Lupton JR. Erbium:YAG cutaneous laser resurfacing. Dermatol Clin 2001; 19:453.
  4. Perez MI, Bank DE, Silvers D. Skin resurfacing of the face with the Erbium:YAG laser. Dermatol Surg 1998; 24:653.
  5. Teikemeier G, Goldberg DJ. Skin resurfacing with the erbium:YAG laser. Dermatol Surg 1997; 23:685.
  6. Ross EV, McKinlay JR, Anderson RR. Why does carbon dioxide resurfacing work? A review. Arch Dermatol 1999; 135:444.
  7. Tierney EP, Eisen RF, Hanke CW. Fractionated CO2 laser skin rejuvenation. Dermatol Ther 2011; 24:41.
  8. Riggs K, Keller M, Humphreys TR. Ablative laser resurfacing: high-energy pulsed carbon dioxide and erbium:yttrium-aluminum-garnet. Clin Dermatol 2007; 25:462.
  9. Tierney EP, Kouba DJ, Hanke CW. Review of fractional photothermolysis: treatment indications and efficacy. Dermatol Surg 2009; 35:1445.
  10. Shah S, Alster TS. Laser treatment of dark skin: an updated review. Am J Clin Dermatol 2010; 11:389.
  11. Chan HH, Manstein D, Yu CS, et al. The prevalence and risk factors of post-inflammatory hyperpigmentation after fractional resurfacing in Asians. Lasers Surg Med 2007; 39:381.
  12. Kim YJ, Lee HS, Son SW, et al. Analysis of hyperpigmentation and hypopigmentation after Er:YAG laser skin resurfacing. Lasers Surg Med 2005; 36:47.
  13. Tan KL, Kurniawati C, Gold MH. Low risk of postinflammatory hyperpigmentation in skin types 4 and 5 after treatment with fractional CO2 laser device. J Drugs Dermatol 2008; 7:774.
  14. Avram MM, Tope WD, Yu T, et al. Hypertrophic scarring of the neck following ablative fractional carbon dioxide laser resurfacing. Lasers Surg Med 2009; 41:185.
  15. Rahman Z, MacFalls H, Jiang K, et al. Fractional deep dermal ablation induces tissue tightening. Lasers Surg Med 2009; 41:78.
  16. Stebbins WG, Hanke CW. Ablative fractional CO2 resurfacing for photoaging of the hands: pilot study of 10 patients. Dermatol Ther 2011; 24:62.
  17. Tierney EP, Hanke CW. Ablative fractionated CO2, laser resurfacing for the neck: prospective study and review of the literature. J Drugs Dermatol 2009; 8:723.
  18. Tierney EP, Hanke CW. Treatment of Poikiloderma of Civatte with ablative fractional laser resurfacing: prospective study and review of the literature. J Drugs Dermatol 2009; 8:527.
  19. Jimenez G, Spencer JM. Erbium:YAG laser resurfacing of the hands, arms, and neck. Dermatol Surg 1999; 25:831.
  20. Goldberg DJ, Meine JG. Treatment of photoaged neck skin with the pulsed Erbium:YAG laser. Dermatol Surg 1998; 24:619.
  21. Goldman MP, Fitzpatrick RE, Manuskiatti W. Laser resurfacing of the neck with the Erbium: YAG laser. Dermatol Surg 1999; 25:164.
  22. Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science 1983; 220:524.
  23. Brightman LA, Brauer JA, Anolik R, et al. Ablative and fractional ablative lasers. Dermatol Clin 2009; 27:479.
  24. Fulton JE Jr, Barnes T. Collagen shrinkage (selective dermaplasty) with the high-energy pulsed carbon dioxide laser. Dermatol Surg 1998; 24:37.
  25. Ross EV, Yashar SS, Naseef GS, et al. A pilot study of in vivo immediate tissue contraction with CO2 skin laser resurfacing in a live farm pig. Dermatol Surg 1999; 25:851.
  26. Walia S, Alster TS. Prolonged clinical and histologic effects from CO2 laser resurfacing of atrophic acne scars. Dermatol Surg 1999; 25:926.
  27. Alster TS, Garg S. Treatment of facial rhytides with a high-energy pulsed carbon dioxide laser. Plast Reconstr Surg 1996; 98:791.
  28. Fitzpatrick RE, Goldman MP, Satur NM, Tope WD. Pulsed carbon dioxide laser resurfacing of photo-aged facial skin. Arch Dermatol 1996; 132:395.
  29. Waldorf HA, Kauvar AN, Geronemus RG. Skin resurfacing of fine to deep rhytides using a char-free carbon dioxide laser in 47 patients. Dermatol Surg 1995; 21:940.
  30. Somoano B, Hantash BM, Fincher EF, et al. The erbium micropeel: a prospective, randomized trial of the effects of two fluence settings on facial photoaging. J Drugs Dermatol 2011; 10:179.
  31. Orringer JS, Rittié L, Hamilton T, et al. Intraepidermal erbium:YAG laser resurfacing: impact on the dermal matrix. J Am Acad Dermatol 2011; 64:119.
  32. Khatri KA, Ross V, Grevelink JM, et al. Comparison of erbium:YAG and carbon dioxide lasers in resurfacing of facial rhytides. Arch Dermatol 1999; 135:391.
  33. Ross EV, Miller C, Meehan K, et al. One-pass CO2 versus multiple-pass Er:YAG laser resurfacing in the treatment of rhytides: a comparison side-by-side study of pulsed CO2 and Er:YAG lasers. Dermatol Surg 2001; 27:709.
  34. Papadavid E, Katsambas A. Lasers for facial rejuvenation: a review. Int J Dermatol 2003; 42:480.
  35. Adrian RM. Pulsed carbon dioxide and long pulse 10-ms erbium-YAG laser resurfacing: a comparative clinical and histologic study. J Cutan Laser Ther 1999; 1:197.
  36. Newman JB, Lord JL, Ash K, McDaniel DH. Variable pulse erbium:YAG laser skin resurfacing of perioral rhytides and side-by-side comparison with carbon dioxide laser. Lasers Surg Med 2000; 26:208.
  37. McDaniel DH, Lord J, Ash K, Newman J. Combined CO2/erbium:YAG laser resurfacing of peri-oral rhytides and side-by-side comparison with carbon dioxide laser alone. Dermatol Surg 1999; 25:285.
  38. Collawn SS. Combination therapy: utilization of CO2 and Erbium:YAG lasers for skin resurfacing. Ann Plast Surg 1999; 42:21.
  39. Dijkema SJ, van der Lei B. Long-term results of upper lips treated for rhytides with carbon dioxide laser. Plast Reconstr Surg 2005; 115:1731.
  40. Tierney EP, Hanke CW. Treatment of CO2 laser induced hypopigmentation with ablative fractionated laser resurfacing: case report and review of the literature. J Drugs Dermatol 2010; 9:1420.
  41. Rubenstein R, Roenigk HH Jr, Stegman SJ, Hanke CW. Atypical keloids after dermabrasion of patients taking isotretinoin. J Am Acad Dermatol 1986; 15:280.
  42. Zachariae H. Delayed wound healing and keloid formation following argon laser treatment or dermabrasion during isotretinoin treatment. Br J Dermatol 1988; 118:703.
  43. Bagatin E, dos Santos Guadanhim LR, Yarak S, et al. Dermabrasion for acne scars during treatment with oral isotretinoin. Dermatol Surg 2010; 36:483.
  44. Hayes DK, Berkland ME, Stambaugh KI. Dermal healing after local skin flaps and chemical peel. Arch Otolaryngol Head Neck Surg 1990; 116:794.
  45. Nestor MS. Prophylaxis for and treatment of uncomplicated skin and skin structure infections in laser and cosmetic surgery. J Drugs Dermatol 2005; 4:s20.
  46. Metelitsa AI, Alster TS. Fractionated laser skin resurfacing treatment complications: a review. Dermatol Surg 2010; 36:299.
  47. Ross EV, Amesbury EC, Barile A, et al. Incidence of postoperative infection or positive culture after facial laser resurfacing: a pilot study, a case report, and a proposal for a rational approach to antibiotic prophylaxis. J Am Acad Dermatol 1998; 39:975.
  48. Walia S, Alster TS. Cutaneous CO2 laser resurfacing infection rate with and without prophylactic antibiotics. Dermatol Surg 1999; 25:857.
  49. Gaspar Z, Vinciullo C, Elliott T. Antibiotic prophylaxis for full-face laser resurfacing: is it necessary? Arch Dermatol 2001; 137:313.
  50. Alt TH. Technical aids for dermabrasion. J Dermatol Surg Oncol 1987; 13:638.
  51. Orringer JS, Kang S, Johnson TM, et al. Tretinoin treatment before carbon-dioxide laser resurfacing: a clinical and biochemical analysis. J Am Acad Dermatol 2004; 51:940.
  52. Hevia O, Nemeth AJ, Taylor JR. Tretinoin accelerates healing after trichloroacetic acid chemical peel. Arch Dermatol 1991; 127:678.
  53. Mandy SH. Tretinoin in the preoperative and postoperative management of dermabrasion. J Am Acad Dermatol 1986; 15:878.
  54. Vagotis FL, Brundage SR. Histologic study of dermabrasion and chemical peel in an animal model after pretreatment with Retin-A. Aesthetic Plast Surg 1995; 19:243.
  55. Mandy SH. Dermabrasion. Semin Cutan Med Surg 1996; 15:162.
  56. Drake LA, Dinehart SM, Goltz RW, et al. Guidelines of care for chemical peeling. Guidelines/Outcomes Committee: American Academy of Dermatology. J Am Acad Dermatol 1995; 33:497.
  57. West TB, Alster TS. Effect of pretreatment on the incidence of hyperpigmentation following cutaneous CO2 laser resurfacing. Dermatol Surg 1999; 25:15.
  58. Batra RS, Jacob CI, Hobbs L, et al. A prospective survey of patient experiences after laser skin resurfacing: results from 2 1/2 years of follow-up. Arch Dermatol 2003; 139:1295.
  59. Batra RS, Ort RJ, Jacob C, et al. Evaluation of a silicone occlusive dressing after laser skin resurfacing. Arch Dermatol 2001; 137:1317.
  60. Bogdan Allemann I, Kaufman J. Fractional photothermolysis--an update. Lasers Med Sci 2010; 25:137.
  61. Hantash BM, Bedi VP, Chan KF, Zachary CB. Ex vivo histological characterization of a novel ablative fractional resurfacing device. Lasers Surg Med 2007; 39:87.
  62. El-Domyati M, Abd-El-Raheem T, Abdel-Wahab H, et al. Fractional versus ablative erbium:yttrium-aluminum-garnet laser resurfacing for facial rejuvenation: an objective evaluation. J Am Acad Dermatol 2013; 68:103.
  63. Kohl E, Meierhöfer J, Koller M, et al. Fractional carbon dioxide laser resurfacing of rhytides and photoageing: a prospective study using profilometric analysis. Br J Dermatol 2014; 170:858.
  64. Clementoni MT, Gilardino P, Muti GF, et al. Non-sequential fractional ultrapulsed CO2 resurfacing of photoaged facial skin: preliminary clinical report. J Cosmet Laser Ther 2007; 9:218.
  65. Lapidoth M, Yagima Odo ME, Odo LM. Novel use of erbium:YAG (2,940-nm) laser for fractional ablative photothermolysis in the treatment of photodamaged facial skin: a pilot study. Dermatol Surg 2008; 34:1048.
  66. Trelles MA, Mordon S, Velez M, et al. Results of fractional ablative facial skin resurfacing with the erbium:yttrium-aluminium-garnet laser 1 week and 2 months after one single treatment in 30 patients. Lasers Med Sci 2009; 24:186.
  67. Dierickx CC, Khatri KA, Tannous ZS, et al. Micro-fractional ablative skin resurfacing with two novel erbium laser systems. Lasers Surg Med 2008; 40:113.
  68. Kotlus BS. Dual-depth fractional carbon dioxide laser resurfacing for periocular rhytidosis. Dermatol Surg 2010; 36:623.
  69. Karsai S, Czarnecka A, Jünger M, Raulin C. Ablative fractional lasers (CO(2) and Er:YAG): a randomized controlled double-blind split-face trial of the treatment of peri-orbital rhytides. Lasers Surg Med 2010; 42:160.
  70. Alster TS, Wanitphakdeedecha R. Improvement of postfractional laser erythema with light-emitting diode photomodulation. Dermatol Surg 2009; 35:813.
  71. Fife DJ, Fitzpatrick RE, Zachary CB. Complications of fractional CO2 laser resurfacing: four cases. Lasers Surg Med 2009; 41:179.
  72. Ross RB, Spencer J. Scarring and persistent erythema after fractionated ablative CO2 laser resurfacing. J Drugs Dermatol 2008; 7:1072.
  73. Tierney EP, Hanke CW. The effect of cold-air anesthesia during fractionated carbon-dioxide laser treatment: Prospective study and review of the literature. J Am Acad Dermatol 2012; 67:436.
  74. Tierney EP, Hanke CW, Petersen J. Ablative fractionated CO2 laser treatment of photoaging: a clinical and histologic study. Dermatol Surg 2012; 38:1777.